Posters – Devices and Imaging NAME OF THE PROJECT NAME OF THE MAIN CONTACT ORGANISATION NAME FIBIR François-Xavier DENIMAL SATT Nord Detection and classification of liver fibrosis from serum by infrared spectroscopy Detection method, gradation (F0-F4) and monitoring of liver fibrosis from serum. Allows the identification of patients with a risk of hepatocellular carcinoma. Technology Infrared spectroscopy coupled with a specific statistical evaluation based on the content of the spectral information obtained from the serum sample. Method validated on more than 100 patients Quick and easy to implement: in serum Non-invasive: no use of biopsy Repeatable: no intra or inter operator variability Analysis of all the spectral characteristics Customers / Target market Industry and competitors Financing need / Commercial opportunity IP – Patent situation Future steps / Milestones All the Hospital laboratories or private laboratories Companies specialized in manufacturing of IVD Devices We are looking for a partner in capacity to develop the product, obtain the CE Mark and/or FDA agreement, market the product and assume the distribution worldwide. 2010 EP 10 757 603 "Serum infrared spectroscopy for non invasive assessment of hepatic fibrosis in patients with chronic liver disease" Production of the device on the base of the prototype and CE Marking This project is the result of collaboration between two teams: Further reading One has a worldwide recognition for its work in biophotonics and technology for health, has signed international partnerships, has participated in many research projects and has developed lots of collaborations with the pharmaceutical industry. The other team is specialized in the screening, diagnosis and treatment of diseases of the gastrointestinal tract, pancreas and liver including digestive cancers. She is heavily involved in translational research between research and clinic. Contact person Mr DENIMAL François-Xavier Pharm. D. SATT Nord, Business Developer francois-xavier.denimal@sattnord.fr